{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:47:31Z","timestamp":1785797251649,"version":"3.56.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ajog.2015.03.055","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T06:26:18Z","timestamp":1428301578000},"page":"196.e1-196.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Novel effects of simvastatin on uterine fibroid tumors: in\u00a0vitro and patient-derived xenograft mouse model study"],"prefix":"10.1016","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0554-132X","authenticated-orcid":false,"given":"Mostafa A.","family":"Borahay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massoud","family":"Motamedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sbrana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan S.","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Al-Hendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Boehning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2015.03.055_bib1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bpobgyn.2008.04.002","article-title":"Incidence, aetiology and epidemiology of uterine fibroids","volume":"22","author":"Okolo","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.03.055_bib2","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/jc.2008-2093","article-title":"Progestins activate the AKT pathway in leiomyoma cells and promote survival","volume":"94","author":"Hoekstra","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2015.03.055_bib3","first-page":"1","article-title":"Hysterectomy surveillance: United States, 1994-1999","volume":"51","author":"Keshavarz","year":"2002","journal-title":"MMWR CDC Surveill Summ"},{"key":"10.1016\/j.ajog.2015.03.055_bib4","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2015.03.055_bib5","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1210\/jcem.87.4.8412","article-title":"Clinical review 145: pleiotropic effects of statins: lipid reduction and beyond","volume":"87","author":"McFarlane","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2015.03.055_bib6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/01.RES.0000070067.64040.7C","article-title":"HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes","volume":"92","author":"Assmus","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.ajog.2015.03.055_bib7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0168-8278(03)00051-5","article-title":"Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells","volume":"38","author":"Rombouts","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ajog.2015.03.055_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2003-37501","article-title":"Statins can inhibit proliferation of human breast cancer cells in\u00a0vitro","volume":"111","author":"Seeger","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ajog.2015.03.055_bib9","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","article-title":"Statin use and reduced cancer-related mortality","volume":"367","author":"Nielsen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.03.055_bib10","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nrc1751","article-title":"Statins and cancer prevention","volume":"5","author":"Demierre","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajog.2015.03.055_bib11","doi-asserted-by":"crossref","first-page":"e110231","DOI":"10.1371\/journal.pone.0110231","article-title":"Statin use and breast cancer survival: a nationwide cohort study from Finland","volume":"9","author":"Murtola","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2015.03.055_bib12","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1111\/febs.12893","article-title":"Statin-induced inhibition of breast cancer proliferation and invasion involves attenuation of iron transport: intermediacy of nitric oxide and antioxidant defence mechanisms","volume":"281","author":"Kanugula","year":"2014","journal-title":"FEBS J"},{"key":"10.1016\/j.ajog.2015.03.055_bib13","first-page":"1180","article-title":"Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase","volume":"14","author":"Kato","year":"2010","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.ajog.2015.03.055_bib14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ygyno.2014.04.007","article-title":"Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials","volume":"133","author":"Liu","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2015.03.055_bib15","doi-asserted-by":"crossref","first-page":"e104521","DOI":"10.1371\/journal.pone.0104521","article-title":"Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis","volume":"9","author":"Habis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2015.03.055_bib16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ygyno.2013.05.025","article-title":"The effect of statins on risk and survival of gynecological malignancies","volume":"130","author":"Lavie","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2015.03.055_bib17","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/jc.2008-2802","article-title":"Simvastatin protects against the development of endometriosis in a nude mouse model","volume":"94","author":"Bruner-Tran","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2015.03.055_bib18","doi-asserted-by":"crossref","DOI":"10.1095\/biolreprod.111.098806","article-title":"Simvastatin decreases invasiveness of human endometrial stromal cells","volume":"87","author":"Sokalska","year":"2012","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ajog.2015.03.055_bib19","doi-asserted-by":"crossref","first-page":"E463","DOI":"10.1210\/jc.2012-3402","article-title":"Effects of simvastatin on retinoic acid system in primary human endometrial stromal cells and in a chimeric model of human endometriosis","volume":"98","author":"Sokalska","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2015.03.055_bib20","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/humrep\/del505","article-title":"High-dose atorvastatin causes regression of endometriotic implants: a rat model","volume":"22","author":"Oktem","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2015.03.055_bib21","doi-asserted-by":"crossref","first-page":"35075","DOI":"10.1074\/jbc.M114.583575","article-title":"Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells","volume":"289","author":"Borahay","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ajog.2015.03.055_bib22","first-page":"1568","article-title":"Rodent model of reproductive tract leiomyomataL establishment and characterization of tumor-derived cell lines","volume":"146","author":"Howe","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajog.2015.03.055_bib23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.LAB.0000017499.51216.3E","article-title":"Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics","volume":"82","author":"Carney","year":"2002","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajog.2015.03.055_bib24","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.4049\/jimmunol.165.5.2712","article-title":"Simvastatin modulates cytokine-mediated endothelial cell adhesion molecule induction: involvement of an inhibitory G protein","volume":"165","author":"Sadeghi","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2015.03.055_bib25","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/ijc.23653","article-title":"Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells: protective effect of catechol-O-methyltransferase","volume":"123","author":"Salama","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2015.03.055_bib26","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ncb1063","article-title":"Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis","volume":"5","author":"Boehning","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ajog.2015.03.055_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1620\/tjem.222.55","article-title":"Establishment of a novel xenograft model for human uterine leiomyoma in immunodeficient mice","volume":"222","author":"Tsuiji","year":"2010","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.ajog.2015.03.055_bib28","first-page":"53","article-title":"NOD\/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models","volume":"324","author":"Ito","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.ajog.2015.03.055_bib29","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2015.03.055_bib30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/pr.111.004994","article-title":"Pharmacological actions of statins: a critical appraisal in the management of cancer","volume":"64","author":"Gazzerro","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ajog.2015.03.055_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0165-6147(97)01147-4","article-title":"Hydrophilicity\/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors","volume":"19","author":"Hamelin","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.ajog.2015.03.055_bib32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/0049825031000066259","article-title":"Uptake of rosuvastatin by isolated rat hepatocytes: comparison with pravastatin","volume":"33","author":"Nezasa","year":"2003","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ajog.2015.03.055_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.CIR.0000022843.76104.01","article-title":"Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids","volume":"106","author":"Chen","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2015.03.055_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2474-8-98","article-title":"Locally applied simvastatin improves fracture healing in mice","volume":"8","author":"Skoglund","year":"2007","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.ajog.2015.03.055_bib35","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.4049\/jimmunol.172.5.2903","article-title":"A\u00a0novel anti-inflammatory role of simvastatin in a murine model of allergic asthma","volume":"172","author":"McKay","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2015.03.055_bib36","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1124\/jpet.105.094136","article-title":"Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin","volume":"316","author":"Thelen","year":"2006","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.ajog.2015.03.055_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/01.ATV.21.1.115","article-title":"Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering","volume":"21","author":"Sparrow","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajog.2015.03.055_bib38","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/01926230590908213","article-title":"Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity","volume":"33","author":"Westwood","year":"2005","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.ajog.2015.03.055_bib39","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1600-0609.2007.00902.x","article-title":"First clinical experience with simvastatin to overcome drug resistance in refractory multiple myeloma","volume":"79","author":"Schmidmaier","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ajog.2015.03.055_bib40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0163-7258(99)00045-5","article-title":"New insights into the pharmacodynamic and pharmacokinetic properties of statins","volume":"84","author":"Corsini","year":"1999","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ajog.2015.03.055_bib41","first-page":"483","article-title":"Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer","volume":"2","author":"Thibault","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajog.2015.03.055_bib42","first-page":"542","article-title":"Dose-finding study of high-dose simvastatin combined with standard chemotherapy in patients with relapsed or refractory myeloma or lymphoma","volume":"91","author":"van der Spek","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.ajog.2015.03.055_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter","year":"2005","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.ajog.2015.03.055_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/dmd.109.030254","article-title":"Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans","volume":"38","author":"Watanabe","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ajog.2015.03.055_bib45","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1172\/JCI109938","article-title":"Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase","volume":"66","author":"Kita","year":"1980","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.ajog.2015.03.055_bib46","unstructured":"US National Library of Medicine. Simvastatin prescribing information (webpage). Bethesda, MD. Available at: http:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=ff4a8eab-17d5-caf4-efba-7e7688202bf5. Accessed June 10, 2014."},{"key":"10.1016\/j.ajog.2015.03.055_bib47","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1124\/dmd.110.037861","article-title":"Role of intestinal cytochrome P450 (P450) in modulating the bioavailability of oral lovastatin: insights from studies on the intestinal epithelium-specific P450 reductase knockout mouse","volume":"39","author":"Zhu","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ajog.2015.03.055_bib48","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0006-291X(89)92773-3","article-title":"Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in\u00a0vivo","volume":"158","author":"Germershausen","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajog.2015.03.055_bib49","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/00498250400015319","article-title":"Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors","volume":"34","author":"Fujino","year":"2004","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ajog.2015.03.055_bib50","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1074\/jbc.M505546200","article-title":"Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function","volume":"281","author":"Qi","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ajog.2015.03.055_bib51","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.nano.2008.11.004","article-title":"Formation of simvastatin nanoparticles from microemulsion","volume":"5","author":"Margulis-Goshen","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ajog.2015.03.055_bib52","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2796.2009.02191.x","article-title":"Nanomedicine based approaches for the delivery of siRNA in cancer","volume":"267","author":"Ozpolat","year":"2010","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.ajog.2015.03.055_bib53","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.trac.2008.01.013","article-title":"HPLC methods for the determination of simvastatin and atorvastatin","volume":"27","author":"Novakova","year":"2008","journal-title":"TrAC Trends in Analytical Chemistry"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815003361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815003361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T21:10:27Z","timestamp":1715461827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937815003361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0002937815003361"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2015.03.055","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel effects of simvastatin on uterine fibroid tumors: in\u00a0vitro and patient-derived xenograft mouse model study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2015.03.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}